![Marylinn Munson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marylinn Munson
Director/Miembro de la Junta en Recombinetics, Inc. .
Perfil
Marylinn Munson is currently a Director at Recombinetics, Inc. She previously worked as a Principal at Molecular Dynamics, Inc., Ngen, Inc., Agilent Technologies, Inc., and Illumina, Inc. She also served as Vice President-Business Development at Biomatrica, Inc. and as a Principal at Amersham Pharmacia Biotech Corp.
Ms. Munson received her undergraduate degree from the University of Oregon.
Cargos activos de Marylinn Munson
Empresas | Cargo | Inicio |
---|---|---|
Recombinetics, Inc.
![]() Recombinetics, Inc. Packaged SoftwareTechnology Services Recombinetics, Inc. operates as a gene editing technology company with a platform in therapeutics development. It uses genetic technologies to improve the health of people, animals, and the environment. The firms offers transplantable cells, tissues and organs for patients, accelerating drug, device therapy, and animal health, welfare and sustainability services. Recombinetics was founded by Scott C. Fahrenkrug in 2008 and is headquartered in Eagan, MN. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Marylinn Munson.
Empresas | Cargo | Fin |
---|---|---|
Biomatrica, Inc.
![]() Biomatrica, Inc. BiotechnologyHealth Technology Biomatrica, Inc. produces reagents and devices used for sample collection and analysis in diagnostics systems, nucleic acid analysis, and bio banking. Its technology is used to protect analyst in samples at the molecular and cellular level, chemically position laboratory workflows on microfluidics chips. The firm’s products include DNAstable, DNAgard, RNAstable and RNAgard. The company was founded by Judy L. Müller-Cohn and Rolf Müller in 2004 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/12/2011 |
Molecular Dynamics, Inc.
![]() Molecular Dynamics, Inc. Wholesale DistributorsDistribution Services Molecular Dynamics, Inc. makes and markets high performance image acquisition and analysis instrumentation | Corporate Officer/Principal | - |
Amersham Pharmacia Biotech Corp. | Corporate Officer/Principal | - |
NGEN INC | Corporate Officer/Principal | - |
AGILENT TECHNOLOGIES, INC. | Corporate Officer/Principal | - |
Formación de Marylinn Munson.
University of Oregon | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
ILLUMINA, INC. | Health Technology |
AGILENT TECHNOLOGIES, INC. | Commercial Services |
Empresas privadas | 5 |
---|---|
Biomatrica, Inc.
![]() Biomatrica, Inc. BiotechnologyHealth Technology Biomatrica, Inc. produces reagents and devices used for sample collection and analysis in diagnostics systems, nucleic acid analysis, and bio banking. Its technology is used to protect analyst in samples at the molecular and cellular level, chemically position laboratory workflows on microfluidics chips. The firm’s products include DNAstable, DNAgard, RNAstable and RNAgard. The company was founded by Judy L. Müller-Cohn and Rolf Müller in 2004 and is headquartered in San Diego, CA. | Health Technology |
Ngen, Inc.
![]() Ngen, Inc. Medical SpecialtiesHealth Technology Ngen, Inc. advanced diagnostics provides physicians and patients worldwide with sophisticated information to predict, diagnose and treat disease. Research and clinical reference labs use the highly accurate and reliable NanoChip(R) Molecular Biology Workstation, NanoChip(R) Electronic Microarray and broad suite of analyte specific reagents to develop diagnostic tests for variety of diseases. Nanogen also offers a broad portfolio of patented nucleic acids chemistries and molecular tools that accelerate genomic analysis and are compatible with many systems. The SynX subsidiary offers a line of point-of-care diagnostic tests and is building expertise in cardiac related health conditions. Nanogen's ten years of pioneering research involving nanotechnology may also have future applications in medical diagnostics, biowarfare and other industries. The company is headquartered in San Diego, CA | Health Technology |
Amersham Pharmacia Biotech Corp. | |
Molecular Dynamics, Inc.
![]() Molecular Dynamics, Inc. Wholesale DistributorsDistribution Services Molecular Dynamics, Inc. makes and markets high performance image acquisition and analysis instrumentation | Distribution Services |
Recombinetics, Inc.
![]() Recombinetics, Inc. Packaged SoftwareTechnology Services Recombinetics, Inc. operates as a gene editing technology company with a platform in therapeutics development. It uses genetic technologies to improve the health of people, animals, and the environment. The firms offers transplantable cells, tissues and organs for patients, accelerating drug, device therapy, and animal health, welfare and sustainability services. Recombinetics was founded by Scott C. Fahrenkrug in 2008 and is headquartered in Eagan, MN. | Technology Services |
- Bolsa de valores
- Insiders
- Marylinn Munson